Aclaris Therapeutics Inc.

(ACRS) Trade

By |

Profile

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively.

Contact Information

Website: www.aclaristx.com
Email: mtung@aclaristx.com
Main Phone: +1 484 324-7933
Address: 640 Lee Road
Address 2: Suite 200
State: PA
City / Town: Wayne
Country: USA
Postal Code: 19087

Issuer Information

Exchange: NGS
CEO: Neal Walker
Employees: 96
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 7.22 $ -0.43 (-5.62%)
Last Price 7.22 Change $ -0.43 Change % -5.62 Tick N/A
Bid 7.20 Bid Size 100.00 Ask 7.25 Ask Size 100.00
Open 7.56 High 7.81 Low 6.86 Prev Close 7.65
Last Trade Volume 1.3 mi 52 Wk Hi 26.25 52 Wk Low 7.51
Market Cap 295.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 40,936,191.00 EPS (TTM) -3.81 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 29 50
Number of Buys 19 30
Number of Sells 10 20
Net Activity -1008 119419
Last 10 Buys Shares
Andrew K. W. Powell 1,000
Frank Ruffo 1,000
Frank Ruffo 1,000
Stephen A. Tullman 1,000
Neal Walker 1,000
Andrew N. Schiff 1,000
Peter Kolchinsky 1,000
Peter Kolchinsky 1,000
Peter Kolchinsky 1,000
Peter Kolchinsky 1,000
Last 10 Sell Shares
Kamil Ali-Jackson 1,000
Kamil Ali-Jackson 1,000
Kamil Ali-Jackson 1,000
Christopher Molineaux 1,000
Anand Mehra 1,000
Kamil Ali-Jackson 1,000
Kamil Ali-Jackson 1,000
Peter Kolchinsky 1,000
Peter Kolchinsky 1,000
Peter Kolchinsky 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 53 53 53 53
Low Target Price Estimate 33 33 33 33
Mean Target Price Estimate 47 47 47 47
Standard Deviation 9.42 9.42 9.42 9.42
Date of Most Recent Estimate 05/22/18 05/22/18 05/22/18 05/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1